A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours


Autoria(s): Stronge, R.L.; Turner, G.B.; Johnston, Brian T; McCance, David R; McGinty, Ann; Patterson, Christopher; Ardill, J
Data(s)

01/11/2008

Formato

application/octet-stream

Identificador

http://pure.qub.ac.uk/portal/en/publications/a-rapid-rise-in-circulating-pancreastatin-in-response-to-somatostatin-analogue-therapy-is-associated-with-poor-survival-in-patients-with-neuroendocrine-tumours(b71cad11-a824-4c30-947a-6e469971ba0b).html

http://dx.doi.org/10.1258/acb.2008.008033

http://pure.qub.ac.uk/ws/files/550663/A%20rapid%20rise%20in%20circulating%20pancreastatin%20etc

http://www.scopus.com/inward/record.url?scp=55949102682&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Stronge , R L , Turner , G B , Johnston , B T , McCance , D R , McGinty , A , Patterson , C & Ardill , J 2008 , ' A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours ' Annals of Clinical Biochemistry , vol 45 , no. 6 , pp. 560-566 . DOI: 10.1258/acb.2008.008033

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1308 #Clinical Biochemistry
Tipo

article